American Healthcare REIT (AHR) Cash & Equivalents (2016 - 2026)

American Healthcare REIT has reported Cash & Equivalents for 11 years, with the latest figure at $119.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 6.33% year-over-year to $119.4 million; the trailing twelve-month figure through Mar 2026 stood at $119.4 million (down 6.33% YoY), and the FY2025 full-year result was $151.8 million, up 23.08% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $119.4 million, down from $151.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $184.4 million in Q3 2025, with the low at $35.2 million in Q3 2023.
• Historically, Cash & Equivalents has averaged $90.2 million across 5 years, with a median of $77.0 million in 2024.
• Annual changes were most pronounced in 2023 — Cash & Equivalents sank 55.71% — and 2024, when it surged 231.66%.
• American Healthcare REIT's Cash & Equivalents stood at $65.1 million in 2022, then plunged by 33.21% to $43.4 million in 2023, then surged by 183.81% to $123.3 million in 2024, then climbed by 23.08% to $151.8 million in 2025, then dropped by 21.33% to $119.4 million in 2026.
• The last three Cash & Equivalents figures came in at $119.4 million (Q1 2026), $151.8 million (Q4 2025), and $184.4 million (Q3 2025), per Business Quant data.